Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

作者: M. Grunnet , J.B. Sorensen

DOI: 10.1016/J.LUNGCAN.2011.11.012

关键词:

摘要: … evaluating tumor markers in lung cancer not involving CEA. … tumor markers are required in order to select lung cancer … Several potential tumor markers have been examined, with the …

参考文章(38)
Hans-Georg Velcovsky, Erich Eigenbrodt, Joachim Schneider, Kathleen Neu, Norbert Katz, Harald Morr, Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer. Anticancer Research. ,vol. 20, pp. 5053- 5058 ,(2000)
T. Peretz, V. Barak, N. Heching, B. Nisman, O. Lyass, G. Amir, J. Lafair, Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Research. ,vol. 19, pp. 3549- 3552 ,(1999)
Amanda Tufman, Rudolph Maria Huber, None, Biological markers in lung cancer: A clinician's perspective. Cancer Biomarkers. ,vol. 6, pp. 123- 135 ,(2010) , 10.3233/CBM-2009-0124
Susan N. Thomas, Ziqiu Tong, Kathleen J. Stebe, Konstantinos Konstantopoulos, Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics Biorheology. ,vol. 46, pp. 207- 225 ,(2009) , 10.3233/BIR-2009-0534
G M Oremek, T H Bruzdziak, H Sauer-Eppel, Value of Tumour and Inflammatory Markers in Lung Cancer Anticancer Research. ,vol. 27, pp. 1911- 1915 ,(2007)
Jan Kulpa, Ewa Wójcik, Marian Reinfuss, Leszek Kołodziejski, Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuron-specific Enolase in Squamous Cell Lung Cancer Patients Clinical Chemistry. ,vol. 48, pp. 1931- 1937 ,(2002) , 10.1093/CLINCHEM/48.11.1931
Takefumi Saito, Hiroichi Ishikawa, [Pro gastrin-releasing peptide (ProGRP)] Nihon rinsho. Japanese journal of clinical medicine. pp. 759- 761 ,(2005)
Niels Reinmuth, Burkhard Brandt, Michael Semik, Wolf-Peter Kunze, Richard Achatzy, Hans H. Scheld, Petra Broermann, Wolfgang E. Berdel, Hans N. Macha, Michael Thomas, Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer Lung Cancer. ,vol. 36, pp. 265- 270 ,(2002) , 10.1016/S0169-5002(02)00009-0
Naruyuki Kobayashi, Shinichi Toyooka, Junichi Soh, Kouichi Ichimura, Hiroyuki Yanai, Hiroshi Suehisa, Shuji Ichihara, Masaomi Yamane, Motoi Aoe, Yoshifumi Sano, Hiroshi Date, Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less Journal of Thoracic Oncology. ,vol. 2, pp. 808- 812 ,(2007) , 10.1097/JTO.0B013E31814617C7